Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
ORIGINAL ARTICLES
Pramipexole Reduces the Prevalence of Fatigue in Patients with Parkinson's Disease
Akihiko MoritaYasuyuki OkumaSatoshi KameiFumihito YoshiiToshimasa YamamotoShiori HashimotoHiroya UtsumiTaku HatanoNobutaka HattoriMiyuki MatsumuraKazushi TakahashiShigeru NogawaYuka WatanabeTomoyuki MiyamotoMasayuki MiyamotoKoichi Hirata
Author information
JOURNAL OPEN ACCESS

2011 Volume 50 Issue 19 Pages 2163-2168

Details
Abstract

Objective The aim of this multicenter cross-sectional study was to assess the relation between fatigue in a large number of Japanese patients with Parkinson's disease (PD) and drugs taken to treat PD.
Method We used the 16-item Parkinson Fatigue Scale (PFS-16), which was designed to assess fatigue exclusively associated with PD. Multiple logistic regression analyses were used to assess the relation between antiparkinson drugs and fatigue in PD.
Results A total of 350 non-demented PD patients were enrolled. Fatigue (PFS score of ≥4) was revealed in 319 patients (91%). Pramipexole was administered to 24% of PD patients. Multiple logistic regression analysis revealed that the administration of Pramipexole was significantly related to low rates of fatigue in PD patients with Hoehn and Yahr stage <3 (p=0.011, odds ratio=5.23, 95% confidence interval; 1.47-18.63).
Conclusion The reduced fatigue in PD patients was observed in taking Pramipexole.

Content from these authors
© 2011 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top